<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887612/" ref="ordinalpos=1885&amp;ncbi_uid=5787842&amp;link_uid=PMC3887612" image-link="/pmc/articles/PMC3887612/figure/F005/" class="imagepopup">Fig. 5.A proposed model for the tau <span class="highlight" style="background-color:">signaling</span> cascade in LPA induced neurite retraction in differentiated Neuro2a cells. LPA increased tau phosphorylation, which was followed by activation of the GSK-3β <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>. The activated GSK-3β and PKA <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> mediated the hyperphosphorylation of tau, which subsequently resulted in differentiated Neuro2a cell neurite retraction..  From: Lysophosphatidic Acid Induces Neurite Retraction in Differentiated Neuroblastoma Cells via GSK-3? Activation. </a></div><br /><div class="p4l_captionBody"></div></div>